2025-12-23 - Analysis Report
Here's a comprehensive analysis of Albemarle Corp (ALB), based on the provided data.

**0) Report Format**
*   Numbers and statistics are presented first.
*   Analysis and interpretations follow the numbers.

**1) Return Rate Comparison (ALB vs. S&P 500)**

*   **Ticker:** ALB
*   **Company Overview:** Albemarle Corp is a specialty chemicals company focused on lithium, bromine specialties, and catalysts.
*   **ALB Cumulative Return:** 40.97%
*   **VOO (S&P 500) Cumulative Return:** 100.88%
*   **Divergence:** -59.9 (Relative Divergence: 19.5)

**Analysis:** Albemarle has significantly underperformed the S&P 500. The current divergence is -59.9%, placing the stock near the lower end of its historical divergence range with a relative divergence of only 19.5. This implies the potential for recovery if ALB outperforms in the future, but also highlights its current underperformance relative to the market.

**Alpha, Beta Analysis Table:**

| Year       | CAGR   | MDD   | Alpha   | Beta   | Cap(B) |
|------------|--------|-------|---------|--------|--------|
| 2015-2017  | 85.0%  | 68.0% | 56.0%   | 0.1    | 15.0   |
| 2016-2018  | 9.0%   | 68.0% | -6.0%   | 0.0    | 9.0    |
| 2017-2019  | -44.0% | 73.9% | -66.0%  | 0.1    | 8.6    |
| 2018-2020  | 44.0%  | 79.4% | 20.0%   | 0.2    | 17.3   |
| 2019-2021  | 149.0% | 79.4% | 103.0%  | -0.1   | 27.4   |
| 2020-2022  | 148.0% | 79.9% | 149.0%  | 0.5    | 25.4   |
| 2021-2023  | -26.0% | 81.9% | -27.0%  | 0.5    | 16.9   |
| 2022-2024  | -152.0%| 81.9% | -172.0% | 0.3    | 10.1   |
| 2023-2025  | -180.0%| 81.9% | -246.0% | -0.9   | 17.1   |

**Analysis of Alpha, Beta Table:**

*   **CAGR:** The Compound Annual Growth Rate shows strong positive performance in some periods (2015-2017, 2019-2022) but significant negative performance in more recent periods (2022-2025). The recent negative CAGR suggests the stock is struggling.
*   **MDD:** The Maximum Drawdown is consistently high, indicating significant volatility and risk. It's been consistently above 68% and now hovers around 80%, signaling substantial potential for losses.
*   **Alpha:** The alpha value indicates the stock's excess return compared to its benchmark. It fluctuates, with large positive alpha in 2015-2017, 2019-2022. However, recent periods (2022-2025) show significantly negative alpha, suggesting ALB is significantly underperforming its benchmark.
*   **Beta:** Beta measures ALB's volatility relative to the market. A beta around 0.1-0.5 suggests that ALB is generally less volatile than the market, but there are periods with negative beta, indicating potential movement opposite to the market. The recent beta trends also suggest a weakening correlation with the broader market.
*   **Cap(B):** Market capitalization shows the highest in the 2019-2021 period and has been declining since, but with a recent bounceback in 2023-2025.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 145.88
*   **Last Market Data:** price: 145.38, previousClose: 145.88, change: -0.34
*   **5-day SMA:** 136.87
*   **20-day SMA:** 129.06
*   **60-day SMA:** 108.23

**Analysis:** The stock price is above all three moving averages, suggesting a short-term upward trend. The 5-day SMA is above the 20-day SMA, which is above the 60-day SMA, reinforcing this upward momentum. The recent small decline (-0.34 change) from the previous close does not negate the overall upward trend indicated by the moving averages.

**3) RSI, PPO, and Expected Return**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommended)
*   **RSI:** 67.31
*   **PPO:** 0.21
*   **Hybrid Signal:** Buy 90% of cash (3 shares - Safe - MRI:0.80) (Cash Ratio: 0% on 2025-12-19)
*   **Recent (20 days) relative divergence change:** 4.0 (+): 단기상승 (Short-term rise)
*   **Expected Return:** 58.4%

**Analysis:**
*   The Market Risk Indicator (MRI) of 0.8 suggests that the investment risk is moderate.
*   The RSI of 67.31 indicates that the stock is approaching overbought territory (typically above 70). This could suggest a potential pullback in the near future.
*   The PPO of 0.21 indicates the price is above its moving average.
*   The hybrid signal suggests a "Buy" recommendation, indicating a favorable short-term outlook.
*   The 20-day relative divergence change indicates short-term upward momentum.
*   The high Expected Return of 58.4% suggests a potentially attractive long-term investment opportunity compared to the S&P 500.

**4) Recent News & Significant Events (Yahoo Finance)**

*   **Positive Outlooks:** Several news articles point to positive developments:
    *   UBS suggests a lithium deficit could boost Albemarle stock.
    *   Lithium prices spiking, with analysts lifting targets.
    *   Albemarle leads S&P 500 as lithium becomes an AI play.
    *   New Analyst Forecast: $ALB Given $150 Price Target.
*   **Strategic Moves:** Other articles highlight Albemarle's strategic moves:
    *   Albemarle using Cesium Offtake Deals to redefine its specialty chemicals edge.
*   **Price Target Increase:**
    *   Albemarle (ALB) Price Target Increased by 13.52% to 123.97.

**Analysis:** The news is predominantly positive, with analysts raising price targets and highlighting the potential benefits from increased lithium demand and Albemarle's strategic initiatives.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (~2.42)
*   **Opinions:** 23
*   **Target Price:** Avg: 124.84 / High: 200.00 / Low: 75.00
*   **Recent Rating Changes:** No information provided on rating changes.

**Analysis:** Analyst consensus is bullish, with a "Buy" rating. However, the average price target of 124.84 is below the current price (145.38), suggesting that analysts are mixed in the short-term. The wide range between the high and low price targets (200.00 / 75.00) indicates considerable uncertainty among analysts regarding the stock's future performance.

**5) Recent Earnings Analysis:**

| Date       | EPS   | Revenue     |
|------------|-------|-------------|
| 2025-11-05 | -1.72 | 1.31 B$     |
| 2025-08-04 | -0.16 | 1.33 B$     |
| 2025-04-30 | 0     | 1.08 B$     |
| 2024-11-06 | -9.45 | 1.35 B$     |
| 2025-11-05 | -9.45 | 1.35 B$     |

**Analysis:**

*   **EPS:** Recent EPS figures are negative, especially the most recent one. While there was a period of EPS near zero, there is an alarming recent trend of loss.
*   **Revenue:** Revenue has been relatively stable, fluctuating between 1.08 B$ and 1.35 B$. This stability in revenue, combined with negative EPS, indicates increasing costs or reduced profitability.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue   | Profit Margin |
|-------------|-----------|---------------|
| 2025-09-30  | $1.31B    | 8.99%         |
| 2025-06-30  | $1.33B    | 14.80%        |
| 2025-03-31  | $1.08B    | 14.51%        |
| 2024-12-31  | $1.23B    | 11.22%        |
| 2024-09-30  | $1.35B    | -7.68%        |

**Capital and Profitability:**

| Quarter     | Equity    | ROE       |
|-------------|-----------|-----------|
| 2025-09-30  | $10.00B   | -1.61%    |
| 2025-06-30  | $10.24B   | 0.22%     |
| 2025-03-31  | $10.03B   | 0.41%     |
| 2024-12-31  | $9.96B    | 0.76%     |
| 2024-09-30  | $10.24B   | -10.44%   |

**Analysis:**

*   **Revenue and Profitability:** Revenue has been relatively stable. Profit margins have fluctuated, with the most recent quarter showing a decrease.
*   **Capital and Profitability:** Equity has remained relatively consistent. ROE has been negative, indicating that the company is not generating profits from shareholders' investments.

**7) Comprehensive Analysis (Summary)**

Albemarle Corp (ALB) presents a mixed picture.

*   **Negative Factors:** ALB has significantly underperformed the S&P 500. Recent earnings are negative. ROE is negative. MDD are consistently high, indicating significant volatility and risk. Recent Alpha indicates ALB is significantly underperforming its benchmark.
*   **Positive Factors:** Recent news is positive, with analysts raising price targets due to increased lithium demand and strategic initiatives. Current stock price is above its 5-day, 20-day, and 60-day moving averages, indicating a short-term uptrend. The expected return is high. The hybrid signal suggests a "Buy" recommendation.
*   **Overall:** ALB is in a volatile sector. The positive news and high expected return suggest potential long-term upside. However, the underperformance against the S&P 500, negative earnings, and high volatility indicate significant risk. Investors should weigh the potential for growth in the lithium market against ALB's current financial struggles before making a decision. The analyst consensus is a "Buy," but the target price range is wide, reflecting the uncertainty. Recent news indicates a price of $150, suggesting a possible analyst upgrade soon.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.